The Californian supplier’s pet segment increased sales by 1% from January to March.
Net sales for Central’s pet portfolio hit $480.2 million (€445.2M) in the second quarter of its fiscal year (FY) 2024. During the same period in 2023, they accounted for $475.2 million (€440M).
The company says the slight increase was led by growth in its consumables business and the acquisition of Virginia-based premium pet food manufacturer TDBBS in late 2023.
Central’s pet business’s operating income was $63 million (€58.4M) from January to March 2024, 13% more than during the same period last year.
In the 6 months to 30 March 2024, net pet sales increased marginally by 0.2% to $889.4 million (€825M). Organic net sales in the category declined 3.8% to $856.9 million (€795M) during the same period, excluding the impact of TDBBS.
Global net sales for Central Garden & Pet were down 1% in Q2 FY 2024 to $900 million ($835M). Gross profit slightly increased to $279 million (€258.8M) against $260 million (€241.2M) in 2023.
The latest articles
CULT Food starts cultivated pet food regulatory race in the US
A subsidiary of the Canadian cell-based firm is to file a feeding trial to seek approval to sell the product in the country.
Ingredients
26 Jul 2024
Purina witnessing a deceleration, admits Nestlé’s CFO
The multinational’s pet portfolio increased sales in the first half of 2024. GlobalPETS dives into the latest earnings.
Global Pet Industry
26 Jul 2024
American biotech companies receive $36 million in investments
California-based NovoNutrients and Digestiva to scale their footprints in alternative protein.
Global Pet Industry
25 Jul 2024
GET THE NEWSLETTER
Weekly newsletter to stay up-to-date
Discover what’s happening in the pet industry. Get the must-read stories and insights in your inbox.